Fine Localization of a Major Disease-Susceptibility Locus for Diffuse Panbronchiolitis  by Keicho, Naoto et al.
Am. J. Hum. Genet. 66:501–507, 2000
501
Fine Localization of a Major Disease-Susceptibility Locus for Diffuse
Panbronchiolitis
Naoto Keicho,1, 2 Jun Ohashi,2 Gen Tamiya,6 Koichiro Nakata,5 Yoshio Taguchi,7 Arata Azuma,3
Nobuya Ohishi,1 Mitsuru Emi,4 Myoung Hee Park,8 Hidetoshi Inoko,6 Katsushi Tokunaga,2 and
Shoji Kudoh3
Departments of 1Respiratory Medicine and 2Human Genetics, Graduate School of Medicine, University of Tokyo, 3Fourth Department of
Internal Medicine and 4Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, and 5Division of Respiratory
Diseases, Toranomon Hospital, Tokyo; 6Department of Genetic Information, Division of Molecular Life Science, Tokai University School of
Medicine, Kanagawa, Japan; 7Department of Respiratory Medicine, Tenri Hospital, Nara, Japan; and 8Department of Clinical Pathology, Seoul
National University College of Medicine, Seoul, Korea
Summary
Diffuse panbronchiolitis affecting East Asians is strongly
associated with the class I human leukocyte antigen
(HLA) alleles. Recent observations suggest that a major
disease-susceptibility gene may be located between the
HLA-B and HLA-A loci in the class I region of the major
histocompatibility complex on chromosome 6. To test
this possibility, we analyzed 14 polymorphic markers in
92 Japanese patients and 93 healthy controls. Of these,
seven marker alleles, includingHLA-B54 andHLA-A11,
were significantly associated with the disease. Maxi-
mum-likelihood haplotype analysis and subsequent di-
rect determination of individual haplotypes identified a
group of disease-associated haplotypes, one of which
contained all seven disease-associated marker alleles.
Another haplotype, containing HLA-B*5504, was also
associated with the disease. All these haplotypes seem
to have diverged from a common ancestral haplotype in
East Asians and share a specific segment containing three
consecutive markers between the S and TFIIH loci in
the class I region. Furthermore, one of the markers
within the candidate region showed the highest delta
value, indicating the strongest association. Of 20 Korean
patients with diffuse panbronchiolitis, 17 also shared the
combination of the disease-associated marker alleles
within the candidate region. These results indicate that
an HLA-associated major susceptibility gene for diffuse
panbronchiolitis is probably located within the 200 kb
in the class I region 300 kb telomeric of the HLA-B locus
on the chromosome 6p21.3.
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Introduction
Diffuse panbronchiolitis is characterized by sinobron-
chial infection and diffuse bilateral micronodular pul-
monary lesions (Fraser et al. 1990) and is considered to
be a complex genetic disease predominantly affecting
East Asians, occurring with a frequency of .00011 in
Japanese. This chronic airway disease was first described
in Japanese patients (Homma et al. 1983) and subse-
quently in Koreans (Kim et al. 1992) and Chinese (Chu
et al. 1992; Tsang et al. 1998), and a few cases have
been reported outside Asia, notably in Asian emigrants
(Høiby 1994; Corne 1996). Most of the patients are the
only affected members in their pedigrees, and disease
association studies have been the sole method of genetic
analysis. An earlier study in the Japanese population
showed that human leukocyte antigen (HLA)-B54,
found only in East Asians, was strongly associated with
the disease (Sugiyama et al. 1990), and this positive as-
sociation was further confirmed at the nucleotide-se-
quence level in our larger study (Keicho et al. 1998).
The disease-associated serotype HLA-B54 corresponded
to a single allele of the HLA-B gene, B*5401. More
recently, an HLA study in the Korean population showed
that HLA-A11 was most significantly associated with
the disease (Park et al. 1999). Considering the close re-
lationship between the Japanese and Korean HLA pro-
files and their genetic background (Tokunaga et al. 1996;
Park et al. 1998), we have hypothesized that a founder
mutation of a putative disease-susceptibility gene located
between the HLA-B and HLA-A loci occurred on an
ancestral chromosome bearing HLA-B54 and HLA-A11
in East Asia. It is conceivable that different historical
recombination events around the disease locus have re-
sulted in disease associations with HLA-B54 in Japanese
and HLA-A11 in Koreans.
When there is a founder effect in a population for
simple Mendelian disorders with relatively high pene-
trance, such as cystic fibrosis and hereditary hemochro-
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matosis in whites, linkage-disequilibrium mapping and
haplotype analysis subsequent to conventional linkage
analysis often have been used successfully for high-res-
olution mapping and cloning of the disease genes (Kerem
et al. 1989; Feder et al. 1996). For complex genetic dis-
eases, however, standard techniques for fine mapping of
disease-susceptibility genes have not been established
yet, mainly because the disease status of chromosomes
is not defined primarily by their pedigree data, because
of low penetrance and phenocopies (Lander and Schork
1994). In the present study, we used 14 genetic markers,
including 9 highly polymorphic microsatellites recently
described in the HLA class I region for the purpose of
refined mapping of HLA-associated diseases (Tamiya et
al. 1998, 1999), and attempted to identify disease-as-
sociated haplotypes and a shared identical-by-descent
critical region.
Subjects and Methods
Subjects
Ninety-two unrelated Japanese patients with diffuse
panbronchiolitis participated in the present study. The
diagnosis of diffuse panbronchiolitis was made in To-
ranomon Hospital, Tenri Hospital, or Nippon Medical
School Hospital, according to the criteria proposed in
1995 by the working group of the Ministry of Health
and Welfare of Japan (Keicho et al. 1998). Ninety-three
normal controls were healthy Japanese volunteers from
the same area of Japan. Genotyping of 20 Korean pa-
tients was also done, although their pedigree data were
not available.
HLA Typing
Class I HLA-A, HLA-B, and HLA-C antigens were
serologically typed by the conventional NIH standard
method with well-defined antisera. A part of their HLA
data was previously described (Keicho et al. 1998). The
presence of HLA-B*5504 encoding B55.2, a rare antigen
in the Japanese population, was further confirmed by
the PCR-based genotyping method (Bannai et al. 1997).
Detection of Single-Nucleotide Polymorphisms in HLA-
E and Transcription-Factor IIH Genes in the Class I
Region
Exon 3 of the HLA-E gene encoding a nonclassical
HLA molecule and exon 1 of the general transcription-
factor (TF) IIH (GTF2H4) gene encoding the 52-kilo-
dalton subunit of the TFIIH were amplified with specific
primers, and variations within the exons were genotyped
by the PCR-SSCP method described previously (Bannai
et al. 1997). “R” and “G” of the HLA-E gene indicate
Arg-107 and Gly-107 caused by a nonsynonymous nu-
cleotide substitution in the coding region (Geraghty et
al. 1992). “T” and “C” of the TFIIH gene represent a
single-nucleotide substitution within its 5′-untranslated
region (GenBank accession numbers AB032121 and
AB023050).
Determination of Microsatellite Alleles
C1_4_3, C1_3_2, C2_2_2, C2_4_4, C4_4_3, C4_2_7,
C4_2_12, and C3_2_12 are all microsatellite markers
recently identified in the HLA class I region, and they
were named as follows: the first part (“C1” to “C4”)
represents the serial numbers of consensus genomic se-
quences or contigs, the second part (“_2” to “_4”) in-
dicates the number of nucleotides in repetition units, and
the last part shows the serial numbers in each group.
Characterization of these markers, their fluorescein-la-
beled PCR primers, and PCR conditions have been de-
scribed elsewhere (Tamiya et al. 1998, 1999). The only
exception is that PCR products of C4_4_3 were digested
with TaqI instead of Sau3AI, and the fragment size was
reduced to !500 bp for the subsequent allele typing. The
PCR products were mixed with deionized-formamide
dye and a size standard marker GENESCAN-500
TAMRA (PE Biosystems), denatured at 94C for 4 min,
and separated on a 4% polyacrylamide sequencing gel
containing 8 M urea in an automated DNA sequencer
ABI PRISM 377 equipped with the Genescan Software
(PE Applied Biosystems). The size of each allele fragment
was determined by comparison with the positions of the
standard marker.
Constructing Haplotypes
Frequencies of predominant haplotypes in the disease
and control populations were estimated by using a com-
puter program presented at the 11th International His-
tocompatibility Workshop (Imanishi et al. 1992a). On
the basis of the maximum-likelihood method, the pro-
gram can estimate frequencies of haplotypes consisting
of up to five loci when the population studied is in
Hardy-Weinberg equilibrium. Furthermore, extended
HLA haplotypes of nine B54 (HLA-B*5401)-positive
patients and two B55.2 (HLA-B*5504)-positive patients
were directly assigned on the basis of genotyping results
of individual family members.
Statistical Analysis
Disease associations with markers were assessed by
the x2 test. When any expected number in the 2 # 2
contingency table was !5, the P value was directly cal-
culated by Fisher’s exact test. The corrected P value (Pc)
was calculated as the P value multiplied by the number
of comparisons made. The odds ratio (OR) was defined
as the cross-product ratio of the numbers shown in the
2 # 2 table. To examine whether genotype frequencies
in the populations are compatible with Hardy-Weinberg
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Table 1
Disease-Associated Marker Alleles
NO. OF
ALLELES
ALLELE
NAMEa
NO. (%) OF
x2 P PcMARKER Patients Controls
HLA-B 21 54 34 (37) 14 (15) 11.5 .0007 .014
HLA-C 5 1 45 (49) 28 (30) 6.8 .0089 .044
C1_4_3 11 441 43 (47) 26 (28) 7.0 .0083 .090
C1_3_2 8 ) ) ) ) ) )
C2_2_2 8 251 81 (88) 64 (69) 10.1 .0015 .011
C2_4_4 10 231 82 (89) 64 (69) 11.5 .0007 .007
C4_4_3 3 ) ) ) ) ) )
TFIIH 2 ) ) ) ) ) )
C4_2_7 12 ) ) ) ) ) )
C4_2_12 9 221 43 (47) 22 (24) 10.8 .0010 .009
HLA-E 2 ) ) ) ) ) )
C3_2_12 18 ) ) ) ) ) )
D6S265 6 ) ) ) ) ) )
HLA-A 8 11 37 (40) 19 (20) 8.6 .0034 .027
a Only alleles with significantly higher frequencies in patients than
in controls ( ) are listed.P ! .05
equilibrium, Hardy-Weinberg exact tests for multiple al-
leles provided by GENEPOP software package were
done (Guo and Thompson 1992). P values !.05 were
considered significant to show a deviation from Hardy-
Weinberg equilibrium.
The degree of association was further evaluated by
the original form of the delta statistic (Bengtsson and
Thomson 1981). This statistic was originally proposed
as a measure of associations of HLA antigens with a
disease in a case-control study. This statistic is not af-
fected by allele-frequency variation at different loci and
has been reported to be more suitable than the odds
ratio, for the estimation of the closest marker to the
primary disease-susceptibility locus, when the specific
alleles of several markers are in linkage disequilibrium
with the disease allele of the susceptibility gene (Bengts-
son and Thomson 1981; Devlin and Risch 1995).
Results
Disease-Associated Marker Alleles
Fourteen markers were analyzed, including nine poly-
morphic microsatellites, single-nucleotide substitutions
within two principal genes, HLA-E and TFIIH, and se-
rotypes of three classical HLA loci in the class I region,
HLA-B, HLA-C, and HLA-A. Of these, alleles with sig-
nificantly higher frequencies in the patient population
than in controls ( ) are listed in table 1. As shownP ! .05
in our previous study (Keicho et al. 1998), the frequency
of HLA-B54 was significantly increased in the patient
population. The frequencies ofHLA-Cw1 andHLA-A11
also were increased, but to lesser degrees. Of the other
marker alleles, C1_4_3-441, C2_2_2-251, C2_4_4-231,
and C4_2_12-221 were associated with the disease
( ). Disease associations with all the markers butP ! .05
C1_4_3-441 were robust, even after the correction for
multiple testing ( ).Pc ! .05
Predominant Haplotypes Estimated in the Control and
Patient Populations
To examine whether the disease-associated marker al-
leles shown in table 1 construct a single haplotype or a
group of disease-associated haplotypes, we first esti-
mated haplotype profiles in the control and patient pop-
ulations by the maximum-likelihood method. HLA-B,
C2_2_2, C2_4_4, C4_2_12, and HLA-A were chosen
for this five-locus analysis, because specific alleles of
these loci exhibited the highest x2 values in table 1. The
distribution of each marker did not deviate fromHardy-
Weinberg equilibrium in both populations, which was a
prerequisite for this analysis (data not shown). HLA-
B52-A24, HLA-B44-A33, HLA-B46-A2, HLA-B7-A24,
and HLA-B54-A24 haplotypes known to be most com-
mon in the Japanese population were identified in the
controls as expected (CN1 to CN5 in table 2). In the
patient population, the HLA-B54-A24 haplotype, HLA-
B54-251-231-221-A24, was predominant (PT1 in table
2) and its frequency was estimated to be 10.9%, which
was remarkably increased from 3.1% in the controls
(CN5). In addition to the HLA-B54-A24 haplotype, two
other B54-containing haplotypes, HLA-B54-251-231-
243-A11 and HLA-B54-251-231-221-A11, also were
identified in the patient population (PT4 and PT5), and
their frequencies in the controls were estimated to be
!1% (data not shown). Of these three haplotypes pre-
dicted in the patient population, HLA-B54-251-231-
221-A11 contained all the disease-associated alleles of
the tested five loci as shown in table 1, and the other
two haplotypes contained four of these five alleles. In
contrast, the HLA-B44-A33 haplotype demonstrated to
be the second-most common haplotype in the controls
(CN2) was not found in the patient population.
Individual Haplotypes Containing HLA-B54
To specify the B54-containing haplotypes character-
izing the patient population, we directly determined in-
dividual haplotypes containing B54. Typing data for 14
markers in 9 patients and their family members were
obtained (1–9 in table 3). B54-containing haplotypes
from patients 1, 2, and probably 3 and 4 represented
the pattern of HLA-B54-251-231-221-A24. Similarly,
the haplotypes from patients 5 and 6 corresponded to
HLA-B54-251-231-243-A11. Haplotype 7 was consis-
tent with HLA-B54-251-231-221-A11 and contained all
the disease-associated marker alleles described in table
1. Haplotypes 8 and 9 did not match any of the three
patterns. All of the B54-containing haplotypes shared
specific alleles from HLA-B to C4_4_3, HLA-B54-Cw1-
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Table 2
Estimation of Predominant Haplotypes in Controls and Patients
MARKER
ESTIMATED PREDOMINANT HAPLOTYPES IN
Controls (n = 93) Patients (n = 92)
CN1a CN2 CN3 CN4 CN5 PT1b PT2 PT3 PT4 PT5
HLA-B 52 44 46 7 54 54 7 52 54 54
C2_2_2 265 277 267 251 251 251 251 265 251 251
C2_4_4 243 259 255 231 231 231 231 243 231 231
C4_2_12 243 223 243 223 221 221 223 243 243 221
HLA-A 24 33 2 24 24 24 24 24 11 11
Haplotype Frequencyc
11.8% 9.1% 4.8% 4.3% 3.1% 10.9% 7.1% 6.0% 4.3% 3.8%
a CN1 to CN5 are haplotypes estimated in the control population.
b PT1 to PT5 are haplotypes estimated in the patient population.
c Only haplotype frequencies 13% are listed.
441-360-251-231-246, whereas alleles from TFIIH to
HLA-A were diverse.
Individual Haplotypes Containing HLA-B*5504
HLA-B*5504 encoding B55.2 is a rare East Asian al-
lele identified in 0.27% of the Japanese population. Sim-
ilarities in nucleotide sequences of the B*5401 encoding
B54 and B*5504 strongly suggest that these two alleles
of the HLA-B gene have diverged from a common an-
cestral form in Asia (Bannai et al. 1997). In a previous
report (Keicho et al. 1998), we showed that the fre-
quencies of both alleles were increased in the patient
population. We evaluated the presence of this allele by
the genotyping method again and confirmed that its fre-
quency was significantly increased in the patient popu-
lation (4.3% in the patients vs. 0% in the controls;
). Extended haplotypes of two B*5504-positiveP = .03
patients were also assigned on the basis of genotyping
results of individual family members (10 and 11 in table
3). Although B*5504-containing haplotypes resembled
the B54-containing haplotypes, the marker alleles from
HLA-B to C1_3_2 in the former haplotypewere different
from those of the latter haplotypes. Thus, a segment
shared by all the B54- and B*5504-containing haplo-
types was 251-231-246 (C2_2_2, C2_4_4, andC4_4_3).
Even those B54 or B*5504-positive patients whose hap-
lotypes could not be determined all carried the combi-
nation of these three alleles (data not shown).
Strength of Associations between the Disease and
Markers
As another approach to identification of the candidate
region, associations between the disease and tested
markers were evaluated. The top of figure 1 shows the
values of the delta statistic and the odds ratio for seven
marker alleles, of which frequencies were significantly
increased in the patient population, as shown in table
1. The peak value of the delta statistic occurred at
C2_4_4, ∼300 kb telomeric of the HLA-B locus. The
odds ratio also reached the peak at C2_4_4, although
it was less prominent than that of the delta values.
The 14 markers used for the haplotype analysis and
their relative physical locations are shown on a map at
the bottom of figure 1. Also, the segment shared among
the disease-associated haplotypes described earlier is ex-
hibited as a critical region on the map.
Marker Typing of 20 Korean Patients with Diffuse
Panbronchiolitis
We further genotyped 20 Korean patients with diffuse
panbronchiolitis. Of the 20 patients, 17 possessed the
combination of C2_2_2-251, C2_4_4-231, and C4_4_3
-246, which are shared among Japanese disease-associ-
ated haplotypes, although phase was not determined be-
cause of the lack of the patients’ pedigree information
(data not shown).
Discussion
We tested the hypothesis that a major disease-suscep-
tibility gene for diffuse panbronchiolitis is located be-
tween the HLA-B and HLA-A loci and that its founder
mutation occurred on an ancestral chromosome bearing
HLA-B54 and A11 alleles. The present data obtained
from the haplotype analysis and genetic association stud-
ies supported our hypothesis and predicted the most
likely region containing the putative susceptibility gene.
First, we attempted to identify disease-associated
marker alleles. Of the 14 markers tested, 7 had a single
allele with a significantly higher frequency in patients
than in controls. Alleles of the other seven markers did
not show significant disease associations, probably be-
cause they were masked by frequent occurrence of iden-
tical-by-state alleles in other common haplotypes. Hap-
lotype analysis by the maximum-likelihood method and
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Table 3
Individual Haplotypes Containing HLA-B54 and B*5504
MARKER
B54-CONTAINING HAPLOTYPES
B*5504-CONTAINING
HAPLOTYPES
1 (SH) 2 (SS) 3 (OM) 4 (YH) 5 (MM) 6 (FT) 7 (IS) 8 (EY) 9 (KT) 10 (EY) 11 (TO)
HLA-B 54 54 54 54 54 54 54 54 54 *5504 *5504
HLA-C 1 1 1 1 1 1 1 1 1 3 3
C1_4_3 441 441 441 441 441 441 441 441 441 445 449
C1_3_2 360 360 360 360 360 360 360 360 360 342 342
C2_2_2 251a 251 251 251 251 251 251 251 251 251 251
C2_4_4 231 231 231 231 231 231 231 231 231 231 231
C4_4_3 246 246 246 246 246/242 246 246 246 246 246 246
TFIIH T T T C T T T/C C T/C T T
C4_2_7 238 238 238 222 234 234 238 228 236/224 234 234
C4_2_12 221 221 221 221 243 243 221 223 243 243 243
HLA-E R/G R R/G G G G R R/G G G/R G
C3_2_12 149 183 151 151 129 129 129 147/129 175 147 129/147
D6S265 8/6b 8 8/6 8/6 8 8/5 7 6/7 1 7 7
HLA-A 24 24 24/26 24/2 11 11/31 11 2 33 11 11
a Shared alleles among all B54 and B*5504-containing haplotypes are underlined.
b Alleles of the microsatellite marker D6S265 are numbered on the basis of their relative size.
subsequent direct determination of individual haploty-
pes identified at least three patterns of disease-associated
haplotypes containing B54. The disease-associated al-
leles including B54 and A11 all were contained in one
of the three haplotypes. Furthermore, all these haplo-
types shared specific alleles of the seven centromeric
markers from HLA-B to C4_4_3, whereas alleles of the
seven telomeric markers from TFIIH to HLA-A were
diverse. These data are consistent with our initial hy-
pothesis that a founder mutation occurred on a B54-
A11-bearing ancestral chromosome and that the present
disease-associated haplotypes have diverged from their
ancestral haplotype through historical recombination
events. The finding that B54-containing haplotypes are
distributed predominantly in Asians (Imanishi et al.
1992b) supports our assumption that a founder muta-
tion occurred in East Asians and also explains why dif-
fuse panbronchiolitis is prevalent mainly in Japanese,
Koreans, and Chinese. In contrast to the B54-containing
haplotype, the B44-A33 haplotype appeared to be de-
creased in the patient population. In fact, B44 and A33
showed negative associations with the disease in the pre-
vious study (Keicho et al. 1998). This may indicate that
the B44-A33 haplotype carries a disease-resistance allele.
Next, we focused on another disease-associated allele,
HLA-B*5504 encoding B55.2, since B*5401 and
B*5504 probably diverged from the common ancestral
form—as was deduced from the close relationship of
their nucleotide sequences and regional distribution in
Asia (Bannai et al. 1997). The frequency of the B*5504,
a rare allele even among Japanese, was significantly in-
creased in the patient population. Although B*5504-
containing haplotypes were closely related to the B54-
containing haplotypes, specific alleles of the centromeric
markers from HLA-B to C1_3_2 diverged from those of
the B54-containing haplotypes. Thus, a shared segment
containing C2_2_2, C2_4_4, and C4_4_3was conserved
by all disease-associated haplotypes identified in this
study, and the most likely region for the putative disease
locus is a 200-kb segment between their flanking mark-
ers. If we consider the physical location of the nearby
genes, this predicted region is roughly bordered by the
S and TFIIH loci, and its center is 300 kb telomeric of
the HLA-B locus.
In addition to the empirical haplotype-based ap-
proach, we further evaluated the strength of associations
between the disease and marker alleles to estimate the
likely location of the susceptibility gene. We applied the
delta statistic as well as the odds ratio for this purpose,
since the statistic is independent of allele frequencies and
advantageous in the estimation of the closest marker to
the disease-susceptibility gene when several marker al-
leles are in linkage disequilibrium with the disease-sus-
ceptibility allele (Bengtsson and Thomson 1981; Devlin
and Risch 1995). The delta statistic showed the prom-
inent peak at C2_4_4. The odds ratio was also highest
at the same locus. These findings were completely con-
sistent with our estimate of the critical region from the
haplotype analysis.
We also found that a majority of Korean patients pos-
sessed the consecutive disease-associated marker alleles
within the critical region. Because phase is unknown in
Korean cases and because the number of those patients
was relatively small for estimating haplotype frequencies
by the maximum-likelihood method, we could not easily
conclude that these alleles are identical by descent. How-
ever, it is likely the case, because of the close genetic
relationship between Japanese and Koreans (Tokunaga
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Figure 1 The delta statistic and odds ratio (top) and the corresponding physical map between the HLA-B and HLA-A loci on the
chromosome 6p21.3 (bottom). On the graph, the X axis shows physical distances in kb from the HLA-B locus. Closed circles indicate the values
of the delta statistic, and closed squares indicate the values of the odds ratio of seven marker alleles, of which frequencies were significantly
increased in the patient population ( ). On the physical map, relative positions of 14 markers, including the other 7 markers used for theP ! .05
haplotype analysis, are shown. B, C, and A on the map represent the HLA-B, HLA-C, and HLA-A loci. A shaded area at the bottom of the
map indicates the critical region deduced from the haplotype analysis. Relative positions of the principal genes around this region are also
exhibited.
et al. 1996). This encourages us to conduct a larger study
comparing disease-associated haplotypes between Jap-
anese and Korean patients in the future. Searching for
shared segments among disease-associated haplotypes in
the genetically related populations may be generalized
as a useful strategy to localize disease mutations, which
occurred on their common ancestral chromosomes.
To our knowledge, no genes have been identified in
this candidate region between the S and TFIIH loci.
However, more than three potential genes are predicted
by database search for expressed sequence tags. There-
fore, further genetic characterization of this region is of
great importance in identification of the disease-suscep-
tibility gene.
Diffuse panbronchiolitis is considered to be a complex
genetic disease, not a simple Mendelian disorder. Nev-
ertheless, we suggest that the strategies used in the pre-
sent study are helpful for fine localization of disease
genes—even for more common diseases—as long as the
population under study fulfills the two major prereq-
uisites: (1) the majority of chromosomes susceptible to
the disease are descended from one or a few transmitting
founders, and (2) the population tested is relatively ho-
mogenous, without recent admixture. The above pre-
requisites are probably met in the case of diffuse pan-
bronchiolitis in the Japanese population. The presence
of a single predominant founder mutation of the sus-
ceptibility gene in East Asians is inferred from the finding
that the disease is associated with mutually related Asian
HLA haplotypes that presumably arose through histor-
ical recombination events. In addition, Japanese have
had a relatively homogenous genetic background, being
geographically isolated by the surrounding sea and with-
out recent large immigration. In conclusion, haplotype
analysis and a measure of associations enabled us to
delineate the most likely region for the HLA-associated
susceptibility gene for diffuse panbronchiolitis.
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